POINT Biopharma Global Investor Relations Material
Latest events
Investor Day 2023
POINT Biopharma Global
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from POINT Biopharma Global Inc
Access all reports
POINT Biopharma Global Inc. is a radiopharmaceutical company focused on developing and commercializing radioligands for cancer treatment. The company aims to enhance precision oncology through a portfolio of targeted radioligand therapies, leveraging its in-house manufacturing capabilities and secured supplies of key medical isotopes. POINT Biopharma actively participates in clinical trials, such as the SPLASH trial for metastatic castration-resistant prostate cancer. The company is headquartered in Indianapolis, Indiana, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PNT
Country
🇺🇸 United States